News & Updates

Tofacitinib induces remission in cutaneous sarcoidosis, granuloma annulare

03 Mar 2020

A small study has recently shown the effectiveness of Janus kinase (JAK) inhibitor tofacitinib in the treatment of cutaneous sarcoidosis and granuloma annulare (GA).

Tofacitinib induces remission in cutaneous sarcoidosis, granuloma annulare

03 Mar 2020

Bermekimab holds therapeutic potential in hidradenitis suppurativa

03 Mar 2020

Interleukin (IL)-1α inhibition with bermekimab appears to be safe and effective in the treatment of moderate-to-severe hidradenitis suppurativa, inducing clinical response without raising substantial safety concerns, according to the results of a phase II trial.

Bermekimab holds therapeutic potential in hidradenitis suppurativa

03 Mar 2020

Rosiglitazone use may increase cardiovascular risk

03 Mar 2020 by

Use of rosiglitazone for the treatment of type 2 diabetes appears to elevate the risk of cardiovascular (CV) events, particularly heart failure, according to the results of an individual patient level data (IPD) meta-analysis.

Rosiglitazone use may increase cardiovascular risk

03 Mar 2020

Aortic risk low in Marfan syndrome patients with FBN1 pathogenic variant

03 Mar 2020

Marfan syndrome patients carrying FBN1 pathogenic variants who receive beta-blocker therapy and who limit strenuous exercise have a low aortic risk when maximal aortic diameter is <50 mm, according to a recent study.

Aortic risk low in Marfan syndrome patients with FBN1 pathogenic variant

03 Mar 2020

E-cigarette dependence leads to stronger, more frequent vaping

03 Mar 2020 by

Symptoms of dependence are relatively common among young people who use e-cigarettes and appear to lead to a more ingrained and intense habit, according to a recent study.

E-cigarette dependence leads to stronger, more frequent vaping

03 Mar 2020

Virtual surveillance well received by testicular cancer patients

03 Mar 2020 by

An electronic surveillance tool generated better compliance and satisfaction rates than standard in-person care among men with stage 1 testicular cancer, according to the interim results of the WATChmAN* trial presented at ASCO GU 2020.

Virtual surveillance well received by testicular cancer patients

03 Mar 2020

Antipsychotic medication exposure in pregnancy ups risk of gestational diabetes

03 Mar 2020 by

Use of antipsychotic medication during pregnancy may increase susceptibility of women to gestational diabetes mellitus, according to the results of a meta-analysis.

Antipsychotic medication exposure in pregnancy ups risk of gestational diabetes

03 Mar 2020

Glecaprevir-pibrentasvir combo safe, effective for HCV infections

03 Mar 2020

Eight-week treatment with glecaprevir plus pibrentasvir is effective for chronic infections of hepatitis C virus (HCV) of genotypes 1–6, without substantial safety concerns, a recent study has found.

Glecaprevir-pibrentasvir combo safe, effective for HCV infections

03 Mar 2020

Nordic diet beneficial for glucose control

03 Mar 2020

Adopting the Nordic diet may help improve serum insulin and the homeostasis model assessment for insulin resistance levels, as shown in the results of a systematic review and meta-analysis.

Nordic diet beneficial for glucose control

03 Mar 2020

CheckMate 040: Nivolumab, cabozantinib ± ipilimumab improves outcomes in aHCC

03 Mar 2020 by

The combination therapy of nivolumab (NIVO) and cabozantinib (CABO) with or without ipilimumab (IPI) demonstrates activity in advanced hepatocellular carcinoma (aHCC), according to the CheckMate 040* study presented at ASCO GI 2020.

CheckMate 040: Nivolumab, cabozantinib ± ipilimumab improves outcomes in aHCC

03 Mar 2020

News & Updates

Filter by Specialty:

Specialty:

Tofacitinib induces remission in cutaneous sarcoidosis, granuloma annulare

Tofacitinib induces remission in cutaneous sarcoidosis, granuloma annulare

Bermekimab holds therapeutic potential in hidradenitis suppurativa

Bermekimab holds therapeutic potential in hidradenitis suppurativa

Rosiglitazone use may increase cardiovascular risk

Rosiglitazone use may increase cardiovascular risk

Aortic risk low in Marfan syndrome patients with FBN1 pathogenic variant

Aortic risk low in Marfan syndrome patients with FBN1 pathogenic variant

E-cigarette dependence leads to stronger, more frequent vaping

E-cigarette dependence leads to stronger, more frequent vaping

Virtual surveillance well received by testicular cancer patients

Virtual surveillance well received by testicular cancer patients

Antipsychotic medication exposure in pregnancy ups risk of gestational diabetes

Antipsychotic medication exposure in pregnancy ups risk of gestational diabetes

Glecaprevir-pibrentasvir combo safe, effective for HCV infections

Glecaprevir-pibrentasvir combo safe, effective for HCV infections

Nordic diet beneficial for glucose control

Nordic diet beneficial for glucose control

CheckMate 040: Nivolumab, cabozantinib ± ipilimumab improves outcomes in aHCC

CheckMate 040: Nivolumab, cabozantinib ± ipilimumab improves outcomes in aHCC